Archive position — measured, not model output
0 likes on Devpost
2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #2,639 place in the like-ranked listing is a tie-break inside that group, not a ranking.
Projects (log scale)
Likes on Devpost. ▲ marks this project's group.
Show the figures
| Likes | Projects | Share of archive |
|---|---|---|
| 0 | 5,592 | 71.2% |
| 1 | 1,758 | 22.4% |
| 2 | 285 | 3.6% |
| 3–4 | 132 | 1.7% |
| 5–9 | 75 | 1.0% |
| 10+ | 14 | 0.2% |
Executive Summary
What the company appears to be
AMMAN is a self-reported AI-powered tool designed to assist doctors in reviewing medical scan report drafts, aiming to reduce errors and identify potential mismatches or pitfalls before finalization. It was submitted as a project for the OpenAI 2026 hackathon.
What changed
The project is described as a hackathon submission with no evidence of prior development, traction, or commercial deployment. The author states it was built using open-source tools and AI models (e.g., GPT-5.6, Codex), but there is no indication of prior use, adoption, or revenue generation.
Single most important open question
Is this a proof-of-concept or an early-stage product with potential for commercialization? The description provides no evidence of customer validation, usage, or business model beyond the hackathon submission.
What The Product Actually Is
The description states that AMMAN is an AI safety check for medical scan report drafts. It is intended to help doctors avoid mistakes and pitfalls in their reports. The tool is built using:
- AI models: GPT-5.6, Codex
- Frameworks: Flask, Python
- Tools: OpenAI API, Pydantic, SQLite, Tkinter, Render
The author describes it as a hackathon project, with no indication of prior development or commercial use.
Evidence
- The description states that AMMAN is an AI tool for reviewing medical scan reports.
- It was built using open-source and AI technologies (e.g., GPT-5.6, Flask, Python).
- It was submitted to the OpenAI 2026 hackathon.
Inference
- The product likely operates as a draft review assistant for radiologists or clinicians.
- It may involve natural language processing and structured data validation.
Not evidenced
- No details on how the AI identifies mismatches or pitfalls.
- No information on whether it integrates with existing medical systems or EHRs.
- No evidence of user interface, workflow integration, or actual use cases beyond a hackathon prototype.
Positioning & Claim Evolution
The author positions AMMAN as an AI safety check for medical scan reports. The tagline states:
“AI safety check for medical scan report drafts to avoid mistakes and pitfalls by Doctors”
This is a self-reported claim about the product’s purpose, not evidence of traction or adoption.
Evidence
- Tagline: “AI safety check for medical scan report drafts to avoid mistakes and pitfalls by Doctors”
- The project was submitted to a hackathon, suggesting it is in early development.
Inference
- The tool aims to reduce human error in clinical documentation.
- It may be positioned as a pre-publication quality control tool.
Not evidenced
- No evidence of prior market research or customer feedback.
- No indication of how the product differentiates from existing tools or workflows.
- No mention of regulatory or compliance considerations.
Target Customer & ICP
The description states that AMMAN is intended for doctors, particularly those who draft medical scan reports. It is described as a tool to help avoid mistakes and pitfalls in their work.
Evidence
- The tagline mentions “by Doctors”
- The product is built for use in clinical environments, specifically for reviewing scan reports
Inference
- The primary user is likely a radiologist or clinician.
- It may be used in hospitals, clinics, or diagnostic centers.
Not evidenced
- No information on whether it targets specific medical specialties (e.g., oncology, cardiology).
- No evidence of customer personas or use cases beyond the general “doctor” role.
- No indication of whether it is intended for individual users or enterprise deployment.
Business Model & Pricing Evidence
The description does not provide any information about a business model or pricing strategy. It is unclear if AMMAN is intended to be sold, licensed, or offered as a service.
Evidence
- No mention of pricing, licensing, or monetization.
- No indication of whether it is a SaaS offering, on-premise tool, or freemium model.
Inference
- As a hackathon project, it may not yet have a defined business model.
- It could be intended for future commercial development or integration into existing platforms.
Not evidenced
- No evidence of revenue streams, customer acquisition costs, or monetization plans.
- No indication of whether the tool is free, paid, or subsidized.
Technical & Delivery Signals
The project was built using a set of open-source and AI technologies:
- AI models: GPT-5.6, Codex
- Frameworks: Flask, Python
- Tools: OpenAI API, Pydantic, SQLite, Tkinter, Render
It is described as a hackathon submission, suggesting it was built quickly with limited resources.
Evidence
- Built with: codex, flask, gpt-5.6, openai-api, pydantic, python, render, sqlite, tkinter
- Submitted to the OpenAI 2026 hackathon
Inference
- The tool likely uses a lightweight architecture for rapid prototyping.
- It may be a desktop or web-based interface with limited scalability.
Not evidenced
- No details on system architecture, data handling, or scalability.
- No evidence of API integrations, cloud infrastructure, or deployment strategy beyond "Render".
- No information on how the AI model is trained or updated.
Traction & Maturity Signals
The description provides no evidence of traction. The project is described as a hackathon submission, with no indication of prior use, adoption, or customer feedback.
Evidence
- Submitted to OpenAI 2026 hackathon
- Team size: 1 (single developer)
Inference
- The product is likely in early development.
- No evidence of user testing, pilot programs, or real-world deployment.
Not evidenced
- No customer data, usage metrics, or feedback.
- No evidence of product iteration or roadmap.
- No indication of whether the tool has been tested with actual medical professionals.
Competitive Context
The description does not provide any information about competitors, market landscape, or existing solutions in the space of AI-assisted clinical documentation or report review.
Evidence
- No mention of competitors
- No reference to existing tools or platforms in the medical AI or reporting space
Inference
- The product may be addressing a gap in clinical report accuracy.
- It could compete with general-purpose AI assistants, EHR systems, or specialized clinical tools.
Not evidenced
- No evidence of competitive analysis or differentiation strategy.
- No indication of how it compares to existing tools or platforms.
Key Risks & Red Flags
- Early-stage prototype: The project is described as a hackathon submission with no prior development or traction.
- Single developer team: Limited resources may hinder scalability or product development.
- No commercialization strategy: No evidence of pricing, monetization, or business model.
- Unclear technical depth: The use of GPT-5.6 and Codex suggests a reliance on external AI services, which may not be scalable or customizable.
- No customer validation: No evidence of real-world testing or feedback from doctors or medical professionals.
Inference
- The tool is likely in the proof-of-concept stage.
- It may require significant development to become viable for clinical use.
Diligence Questions To Ask The Founders
- What specific types of mismatches or pitfalls does AMMAN identify in scan reports?
- How does it integrate with existing medical systems (e.g., EHRs)?
- Has the tool been tested with actual doctors or clinicians?
- What is the intended business model for AMMAN?
- Is there a plan to scale beyond the hackathon prototype?
- What are the regulatory considerations for deploying such a tool in clinical settings?
- How does it handle data privacy and security in medical environments?
Investment/Partnership Verdict
Not evidenced
The description provides no evidence of traction, revenue, customer adoption, or business model. The project is described as a hackathon submission with a single developer and no indication of commercial viability.
Confidence Low This analysis is based entirely on self-reported information from a hackathon submission. There is no evidence of product-market fit, customer validation, or development beyond the prototype stage.
Inference
- The project may be an early-stage idea with potential for further development.
- It would require significant due diligence to assess commercial viability or scalability.
Source
Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.
The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.